Why it’s important to call the Johnson & Johnson vaccine review phase a ‘pause’

Helen Salisbury: Will additional roles save general practice?
19 April 2021
Defects in a specific cell type may cause ulcerative colitis
19 April 2021

Why it’s important to call the Johnson & Johnson vaccine review phase a ‘pause’

As the distribution of the Johnson & Johnson vaccine remains on hold while federal health officials review a potential blood-clotting side effect, public health authorities and scientists find themselves in a delicate position when it comes to the messaging about the safety and efficacy of COVID-19 vaccines to the United States public, two Northeastern scholars of public health law and communications say.

Comments are closed.